BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 10978146)

  • 1. Identification of the major positional isomer of pegylated interferon alpha-2b.
    Wang YS; Youngster S; Bausch J; Zhang R; McNemar C; Wyss DF
    Biochemistry; 2000 Sep; 39(35):10634-40. PubMed ID: 10978146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, biology, and therapeutic implications of pegylated interferon alpha-2b.
    Youngster S; Wang YS; Grace M; Bausch J; Bordens R; Wyss DF
    Curr Pharm Des; 2002; 8(24):2139-57. PubMed ID: 12369859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural, kinetic, and thermodynamic analysis of the binding of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers to the extracellular domain of the receptor IFNAR2.
    Dhalluin C; Ross A; Huber W; Gerber P; Brugger D; Gsell B; Senn H
    Bioconjug Chem; 2005; 16(3):518-27. PubMed ID: 15898717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biologic characterization of pegylated recombinant IFN-alpha2b.
    Grace M; Youngster S; Gitlin G; Sydor W; Xie L; Westreich L; Jacobs S; Brassard D; Bausch J; Bordens R
    J Interferon Cytokine Res; 2001 Dec; 21(12):1103-15. PubMed ID: 11798469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pegylating IFNs at his-34 improves the in vitro antiviral activity through the JAK/STAT pathway.
    Grace MJ; Cutler D
    Antivir Chem Chemother; 2004 Nov; 15(6):287-97. PubMed ID: 15646642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and biophysical characterization of the 40 kDa PEG-interferon-alpha2a and its individual positional isomers.
    Dhalluin C; Ross A; Leuthold LA; Foser S; Gsell B; Müller F; Senn H
    Bioconjug Chem; 2005; 16(3):504-17. PubMed ID: 15898716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Interferon alpha-2b modified with polyethylene glycol].
    Wu Y; Zhai Y; Lei J; Ma G; Su Z
    Sheng Wu Gong Cheng Xue Bao; 2008 Sep; 24(9):1658-63. PubMed ID: 19160853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Site of pegylation and polyethylene glycol molecule size attenuate interferon-alpha antiviral and antiproliferative activities through the JAK/STAT signaling pathway.
    Grace MJ; Lee S; Bradshaw S; Chapman J; Spond J; Cox S; Delorenzo M; Brassard D; Wylie D; Cannon-Carlson S; Cullen C; Indelicato S; Voloch M; Bordens R
    J Biol Chem; 2005 Feb; 280(8):6327-36. PubMed ID: 15596441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of PEGylated proteins in polyacrylamide gels by reverse staining with zinc and imidazole salts.
    Hardy E; Ramón J; Saez V; Báez R; Tejeda Y; Ruiz A
    Electrophoresis; 2008 Jun; 29(11):2363-71. PubMed ID: 18449861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-acting, highly potent interferon alpha-2 conjugate created using site-specific PEGylation.
    Rosendahl MS; Doherty DH; Smith DJ; Carlson SJ; Chlipala EA; Cox GN
    Bioconjug Chem; 2005; 16(1):200-7. PubMed ID: 15656592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon alpha-2a (PEGASYS).
    Foser S; Schacher A; Weyer KA; Brugger D; Dietel E; Marti S; Schreitmüller T
    Protein Expr Purif; 2003 Jul; 30(1):78-87. PubMed ID: 12821324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
    Ramon J; Saez V; Baez R; Aldana R; Hardy E
    Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positional isomers of monopegylated interferon alpha-2a: isolation, characterization, and biological activity.
    Monkarsh SP; Ma Y; Aglione A; Bailon P; Ciolek D; DeBarbieri B; Graves MC; Hollfelder K; Michel H; Palleroni A; Porter JE; Russoman E; Roy S; Pan YC
    Anal Biochem; 1997 May; 247(2):434-40. PubMed ID: 9177709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specific PEGylation at histidine tags.
    Cong Y; Pawlisz E; Bryant P; Balan S; Laurine E; Tommasi R; Singh R; Dubey S; Peciak K; Bird M; Sivasankar A; Swierkosz J; Muroni M; Heidelberger S; Farys M; Khayrzad F; Edwards J; Badescu G; Hodgson I; Heise C; Somavarapu S; Liddell J; Powell K; Zloh M; Choi JW; Godwin A; Brocchini S
    Bioconjug Chem; 2012 Feb; 23(2):248-63. PubMed ID: 22243664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].
    Pokholenko IaA; Porubleva LV; Dubeĭ IIa; Rebriev AV; Sutugina LP; Gromovoĭ TIu; Pokrovskiĭ VA; Obolenskaia MIu; Chernykh SI
    Ukr Biokhim Zh (1999); 2008; 80(6):92-100. PubMed ID: 19351063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pegylation and Cell Based Bioassay of Human Interferon-α2b Along its Docking Studies and Effect on Plasma Half-Life.
    Shahzadi SK; Qadir MA; Mahmood N; Ahmed M
    Protein Pept Lett; 2020; 27(3):219-224. PubMed ID: 31612813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of a pegylated interferon-alpha2a product by a customised and validated reverse phase-high performance liquid chromatography method.
    El Ghazaly M; Meager A; Zikry H; Ebaed M; Shaker S; Mueller F; Rohde J
    J Pharm Biomed Anal; 2013 Oct; 84():48-52. PubMed ID: 23797040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjugation of PolyPEG to interferon alpha extends serum half-life while maintaining low viscosity of the conjugate.
    Podobnik B; Helk B; Smilović V; Škrajnar Š; Fidler K; Jevševar S; Godwin A; Williams P
    Bioconjug Chem; 2015 Mar; 26(3):452-9. PubMed ID: 25629733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced circulating half-life and antitumor activity of a site-specific pegylated interferon-alpha protein therapeutic.
    Bell SJ; Fam CM; Chlipala EA; Carlson SJ; Lee JI; Rosendahl MS; Doherty DH; Cox GN
    Bioconjug Chem; 2008 Jan; 19(1):299-305. PubMed ID: 18020402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.